Saba Capital Management, L.P. bought HQL
June 4, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 33,357 shares of Abrdn Life Sciences Investors at $13.50 per share, a transaction worth $450.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
33,357
Price
$13.50
Total value
$450.3K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 4, 2024
Filing dateJune 5, 2024
Shares owned after3,354,025
OwnershipIndirect
10b5-1 planNo
AmendedNo